期刊文献+

靶向survivin siRNA与5-Fu协同抑制MCF-7细胞增殖 被引量:5

Synergistic Inhibitory Effect of survivin siRNA in Combination with 5-Fu on Inhibiting Proliferation of MCF-7 Cells
下载PDF
导出
摘要 目的研究以survivin为靶标的小干扰RNA(siRNA)与化疗药5-Fu联合应用抑制MCF-7细胞增殖的作用。方法以脂质体为载体,将survivin siRNA转染至MCF-7细胞中,用四氮唑盐(MTT)法染色并计算siRNA联用5-Fu对MCF-7细胞的抑制率,用SAS统计软件及金正均Q值法进行统计分析。结果单用5-Fu,IC50为4.42μg/ml;加入5nmol/LsiRNA后,IC50降为1.18μg/ml;siRNA与5-Fu联用的抑制作用较单用5-Fu强(F=26.74,P<0.01);Q值分析表明survivin siRNA与中低浓度的5-Fu联用,有较好的协同作用(Q≥1.15)。结论survivinsiRNA与5-Fu联用,可显著增强对MCF-7细胞增殖的抑制,提高肿瘤细胞对化疗药物的敏感性。 Objective To investigate the effect of the small interfering RNA(siRNA) targeted to survivin in combination with 5-Fu on inhibition the of MCF-7 cells proliferation. Methods A siRNA targeted to survivin was synthesized, siRNA was transfected into MCF-7 by lipofectin. Cell growth activity was evaluated by MTT assay. SAS software and Jin Zhenjun Method were used to evaluate the combination effects of siRNA and 5-Fu. Results Combination treatment with 5 nmol/L siRNA reduced the IC50 of 5- Fu from 4.42 μg/ml to 1.18 μg/ml;the inhibitory of combination treatment on MCF-7 cells was higher than that of 5-Fu alone (F= 26. 74,P〈0. 01. And synergism(Q≥1. 15)was observed at the lower concentration of 5-Fu with combination of siRNA. Conclusion siRNA may enhance the effectiveness of 5-Fu on inhibiting the proliferation of MCF-7 cells.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2008年第4期255-257,共3页 Cancer Research on Prevention and Treatment
基金 陕西省科技公关资助项目(2006k09-G9 2007K09-06(4)) 国家自然科学基金资助项目(30500600)
关键词 RNA干扰 化学疗法 联合治疗 MCF-7 RNA interfer Chemotherapy Combination therapy MCF-7
  • 相关文献

参考文献3

二级参考文献11

  • 1Deveraux QL, Takahashi R, Salvesen GS, et al. X-linked IAP is a direct inhibitor of cell-death proteases [J] . Nature, 1997, 388(6639): 300 - 304.
  • 2Rohayem J, Diestelkoetter P, Weigle B, et al. Antibody response to the tumor-associated inhibitor of apoptosis protein in cancer patients [J]. Cancer Res, 2000, 60(7): 1815 - 1817.
  • 3Shin S, Sung BJ, Cho YS, et al. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and caspase-7 [J].Biochemistry, 2001, 40 (4): 1117 - 1123.
  • 4Koch CA, Vortmeyer AO, Diallo R, et al. Survivin: a novel neuroendocrine marker for pheochromocytoma [J]. Eur J Endocrinol, 2002, 146 (3): 381 - 388.
  • 5Ikeguchi M, Ueda T, Sakatani T, et al. Expression of survivin messenger RNA correlates with poor prognosis in patient with hapatocellular carcinoma [J] . Diagn Mol Pathol, 2002, 11 (1):33 - 40.
  • 6Chakravarti A, Noll E, Black PM, et al. Quantitatively determined survivin expression levels are of prognostic value in human gliomas [J]. J Clin Oncol, 2002, 20(4): 1063 - 1068.
  • 7Tanaka K, Iwamoto S, Gon G,et al. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas [J]. Clin Cancer Res,2000, 6:127 - 134.
  • 8Adida C, Berrebi D, Peuchmaur M, et al. Anti-apoptosis gene,survivin, and prognosis of neuroblastoma [J]. Lancet, 1998, 351(9106): 882 - 886.
  • 9戴体俊.协同、拮抗等定义亟待统一[J]生理科学进展,1997(04).
  • 10江明性.药理学[M]人民卫生出版社,1989.

共引文献164

同被引文献31

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部